Hotchkis & Wiley Capital Management’s Zimmer Biomet ZBH Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $149M | Sell |
|
|||||
2025
Q1 | $186M | Sell |
|
|||||
2024
Q4 | $176M | Sell |
|
|||||
2024
Q3 | $189M | Buy |
|
|||||
2024
Q2 | $128M | Buy |
|
|||||
2024
Q1 | $154M | Buy |
|
|||||
2023
Q4 | $141M | Sell |
|
|||||
2023
Q3 | $135M | Sell |
|
|||||
2023
Q2 | $177M | Sell |
|
|||||
2023
Q1 | $158M | Sell |
|
|||||
2022
Q4 | $158M | Sell |
|
|||||
2022
Q3 | $145M | Sell |
|
|||||
2022
Q2 | $149M | Sell |
|
|||||
2022
Q1 | $188M | Sell |
|
|||||
2021
Q4 | $192M | Buy |
|
|||||
2021
Q3 | $155M | Sell |
|
|||||
2021
Q2 | $177M | Sell |
|
|||||
2021
Q1 | $187M | Sell |
|
|||||
2020
Q4 | $195M | Sell |
|
|||||
2020
Q3 | $258M | Sell |
|
|||||
2020
Q2 | $252M | Buy |
|
|||||
2020
Q1 | $202M | Buy |
|
|||||
2019
Q4 | $181M | Buy |
|
|||||
2019
Q3 | $159M | Sell |
|
|||||
2019
Q2 | $148M | Buy |
|
|||||
2019
Q1 | $160M | Sell |
|
|||||
2018
Q4 | $139M | Buy |
|
|||||
2018
Q3 | $173M | Sell |
|
|||||
2018
Q2 | $149M | Sell |
|
|||||
2018
Q1 | $148M | Buy |
|
|||||
2017
Q4 | $161M | Sell |
|
|||||
2017
Q3 | $157M | Sell |
|
|||||
2017
Q2 | $182M | Sell |
|
|||||
2017
Q1 | $190M | Sell |
|
|||||
2016
Q4 | $164M | Buy |
|
|||||
2016
Q3 | $188M | Sell |
|
|||||
2016
Q2 | $181M | Sell |
|
|||||
2016
Q1 | $221M | Sell |
|
|||||
2015
Q4 | $247M | Sell |
|
|||||
2015
Q3 | $230M | Buy |
|
|||||
2015
Q2 | $143M | Sell |
|
|||||
2015
Q1 | $156M | Sell |
|
|||||
2014
Q4 | $165M | Sell |
|
|||||
2014
Q3 | $148M | Sell |
|
|||||
2014
Q2 | $160M | Sell |
|
|||||
2014
Q1 | $151M | Buy |
|
|||||
2013
Q4 | $142M | Sell |
|
|||||
2013
Q3 | $150M | Sell |
|
|||||
2013
Q2 | $137M | Buy |
|